NOVT news

Novanta Inc reported a 10% rise in Q2 2026 GAAP revenue to $266 million, driven by exceptional growth exceeding market expectations. The company also generated $64.9 million in operating cash flow, demonstrating strong market performance and operational efficiency.

Novanta Inc. has completed the acquisition of Riverpoint Medical to advance its strategic footprint in high-growth minimally invasive surgical consumables; the deal is expected to double recurring medical consumables revenue and add $0.18 to $0.25 of adjusted EPS in 2027.

Novanta Inc. entered into an equity purchase agreement to acquire Runway Buyer LLC's medical technologies business through its subsidiary Novanta Medical Technologies Corp. The acquisition expands Novanta's medical device portfolio and strengthens its position in healthcare markets.